VAERS reports by lot

Novartis Vaccines Meningococcal lot J52PN: VAERS reports

33 VAERS reports list lot J52PN as a Novartis Vaccines Meningococcal vaccine, received between 2023-06-16 and 2024-07-24. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
33
Reports
0%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1723%
General / Systemic (non-local)1520%
Neurological1317%
Cardiac / Cardiovascular811%
Gastrointestinal811%
Musculoskeletal79%
Allergic / Anaphylactic34%
Respiratory23%
Dermatological (non-injection-site)23%

Where reports came from

U.S. state of the reporter, where given (top 12).

Georgia7
Texas4
Massachusetts2
Virginia2
Michigan2
Indiana2
Florida1
Pennsylvania1
Wisconsin1
Kentucky1
California1
Ohio1

Reports by month received

2023-065
2023-076
2023-083
2023-092
2023-103
2023-111
2024-045
2024-054
2024-063
2024-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.